Mikrobiomik

Bilbao, Spain · Founded 2018 · Privately Held (backing)

Operator of a biopharmaceutical company intended to research, develop, produce, and market biological drugs based on the human microbiome. Mikrobiomik is based in Bilbao, Spain and was founded in 2018. Its last known valuation is $16.7 million. It has raised $10.3 million.

Last price · $/share
—
Implied valuation
$16.7M
Total raised
$10.3M
Last round
—
What is Mikrobiomik worth?
$16.7Mlast known valuation
Free account
More of Mikrobiomik with a free account
  • ·Watch Mikrobiomik: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mikrobiomik funding history

No rounds on record

No funding rounds for Mikrobiomik are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Mikrobiomik valuation

Mikrobiomik's last known valuation is $16.7 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Mikrobiomik's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Mikrobiomik, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Mikrobiomik

What is Mikrobiomik worth?
Mikrobiomik's last known valuation is $16.7M.
How much has Mikrobiomik raised?
Mikrobiomik has raised $10.3M in total funding across its recorded rounds.